Just two years ago, a raised eyebrow (perfectly arched, of course) moment: consumer health biotech company Timeline raised $66 million in a Series D that included strategic investments from both L’Oréal and Nestlé.
So what would two of the biggest names in consumer goods want with a Swiss biotech? The same thing we’re all after — a youthful glow — as wellness consumers have raised the stakes. They don’t just want to feel younger, they want to look it.
Timeline’s nutritional supplements and skin health products feature Mitopure, a well-researched, proprietary form of Urolithin A that supports healthy aging.
It was a hint of things to come. L’Oréal, which owns Lancôme, led the round, and now the fruits have ripened.
The perfume and cosmetics house unveiled Absolute Longevity MD, a five-product anti-aging line accompanied by a newly formed Advisors Board of board-certified physicians, which includes physician and wellness personality Dr. Gabrielle Lyon.
The line (priced from $155 to $175) includes Anticipate Cream, targeted to those under 35, Intercept Serum and Cream for those in midlife and Reset for mature consumers.
Along with the skin longevity products, there’s a beauty tech twist. Lancôme has tapped Korea’s NanoEntek for Cell BioPrint, which analyzes five skin-surface biomarkers, helps interpret the skin’s visible biological age and offers personalized skincare protocols.
The beauty giant made the reveal at this month’s American Academy of Dermatology Annual Meeting in Denver — a fitting venue, according to Lancôme global brand president Vania Lacascade.
“Lancôme’s presence at the AAD convention marks a defining step into a new era of skin longevity,” she said. “By unveiling Absolue Longevity MD at the heart of the medical community, we are helping bridge the
gap between cutting-edge science and women’s everyday lives.”
The Absolue Longevity MD range will be available April 20 online and at select luxury retailers nationwide beginning May 1.
Skincare Takes a Wellness Turn
Wellness is big business, and big beauty knows it. Skin longevity was named one of 2026’s top wellness trends by the Global Wellness Institute, and even med-spas are seeing growing consumer interest.
LaserAway co-founder Scott Heckmann calls it a “second wave,” a downstream effect of the GLP-1 boom, as patients address related concerns like facial volume loss or continue investing in themselves because they feel better.
Capital is following.
Last summer, OneSkin landed $20 million from Prelude Growth Partners. The growth equity firm approached the biotech skincare startup, which counts Jennifer Aniston as a fan, with an unsolicited offer. That same month, Magic Science Corporation, the health sciences company behind Magic Molecule, received an undisclosed investment from private equity firm NexPhase Capital.
Fitness operators are also paying attention — some are even putting beauty products in their locker rooms. Chelsea Piers Fitness features Malin + Goetz in its New York and Connecticut locations, Life Time features Kiehl’s products at its New York City clubs and Equinox is reportedly adding New York–based luxury fragrance brand Le Labo across its clubs.
